BTK-IN-23
CAS No. 1227206-13-4
BTK-IN-23( —— )
Catalog No. M10877 CAS No. 1227206-13-4
BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBTK-IN-23
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.
-
DescriptionBTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM; displays 5-fold and 77-fold selectivity over BMX and TEC, >300-fold selectivity over FGR, SRC and MELK; demonstrates potent inhibition of anti-IgE stimulated CD63 expression on basophils, with an EC50 of 257 nM; shows improved stability compared to GDC-0834.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1227206-13-4
-
Formula Weight529.594
-
Molecular FormulaC27H24FN7O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(6-fluoro-2-methyl-3-(5-((5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)amino)-6-oxo-1,6-dihydropyridazin-3-yl)phenyl)benzo[b]thiophene-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Young WB, et al. Bioorg Med Chem Lett. 2016 Jan 15;26(2):575-9.
molnova catalog
related products
-
BTK IN-1
BTK IN-1 (SNS062 analog) is an effective BTK inhibitor (IC50: <100 nM).
-
Fenebrutinib
An orally bioavailable, selective, non-covalent and reversible BTK inhibitor with IC50 of 2-9 nM.
-
CGI-1746
CGI-1746 is a potent, highly selective, second-generation BTK inhibitor with IC50 of 1.9 nM.
Cart
sales@molnova.com